Literature DB >> 14525889

"Polypill" to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable.

Andrea Messori, Benedetta Santarlasci, Sabrina Trippoli, Monica Vaiani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14525889      PMCID： PMC214164          DOI： 10.1136/bmj.327.7418.808-c

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  A cure for cardiovascular disease? Combination treatment has enormous potential, especially in developing countries.

Authors:  Anthony Rodgers
Journal:  BMJ       Date:  2003-06-28

2.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28
  2 in total
  2 in total

1.  Effectiveness calculation in economic analysis: the case of statins for cardiovascular disease prevention.

Authors:  Oscar H Franco; Ewout W Steyerberg; Anna Peeters; Luc Bonneux
Journal:  J Epidemiol Community Health       Date:  2006-10       Impact factor: 3.710

2.  The polypill: at what price would it become cost effective?

Authors:  Oscar H Franco; Ewout W Steyerberg; Chris de Laet
Journal:  J Epidemiol Community Health       Date:  2006-03       Impact factor: 3.710
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.